Stryker reported first-quarter revenue of $6.02 billion, missing the $6.33 billion consensus, while adjusted EPS of $2.60 fell short of the $2.98 estimate, after a March 11 cyberattack and $118 million in restructuring charges. Intuitive Surgical posted revenue of $2.77 billion, up 23%, with non-GAAP EPS of $2.50 topping the $2.11 consensus, driven by a roughly 16% rise in worldwide da Vinci procedures and 232 da Vinci 5 placements out of 431 total systems. Stryker's orthopaedic franchise showed resilience with 4.7% knee growth and 3.7% hip growth, while its vascular arm, boosted by the Inari deal, jumped 27.5%, and free cash flow surged 227% to $415 million. Intuitive guided da Vinci procedure growth of 13.5% to 15.5%, a step down from 18% in 2025, and faces a tariff hit of roughly 1% of revenue. Stryker trades at about 22 times forward earnings versus Intuitive's premium 39 times, and Stryker maintained full-year organic growth guidance of 8% to 9.5%.
Intuitive Surgical IncRevenue and EPS beat driven by 16% rise in da Vinci procedures and 232 da Vinci 5 placements.
Stryker CorporationQ1 revenue and EPS missed estimates due to a March 11 cyberattack and restructuring charges.
NVIDIA Corporation